Objective Few studies examined substance use in cancer patients. The aims of this
systematic review were to summarize this evidence, identify methodological limitations, and …

Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the
natural disease process. This review focuses on the most common causes of chronic pain in …

The management of chronic cancer pain remains challenging and complex, with the process
often involving a variety of pharmacological and non-pharmacological approaches. Recent …

Importance Opioid use disorder (OUD) is an important comorbidity in individuals with
advanced cancer, in whom pain is common. Full-agonist opioid medications are the …

Opinion statement Preventing depression in cancer patients on long-term opioid therapy
should begin with depression screening before opioid initiation and repeated screening …

Background: The majority of Palliative Care (PC) clinicians report recently caring for a
person with a Substance Use Disorder (SUD). The impact of an untreated SUD is associated …

PURPOSE: Among cancer survivors who have completed curative-intent treatment, the high
prevalence and adverse consequences of chronic pain are well documented. Yet, research …

Context The prevalence of chronic pain in cancer survivors is double that of the general US
population. Opioids have been the foundation of cancer pain management for decades; …

Cancer survivors are a heterogeneous population with high rates of chronic pain and
prescription opioid receipt. Nuanced guidance on how to approach opioid decisions for …

Background: Opioid misuse and substance use disorders (SUDs) including opioid use
disorder (OUD) are common and negatively impact quality of life. Hospice clinicians' …